126 related articles for article (PubMed ID: 28527578)
21. Gene silencing by nuclear orphan receptors.
Zhang Y; Dufau ML
Vitam Horm; 2004; 68():1-48. PubMed ID: 15193450
[TBL] [Abstract][Full Text] [Related]
22. Collective repression of the hepatitis B virus enhancer II by human TR4 and TR2 orphan receptors.
Lin TJ; Yang RY; Lee HJ
Hepatol Res; 2008 Jan; 38(1):79-84. PubMed ID: 17645519
[TBL] [Abstract][Full Text] [Related]
23. Spermatogenesis and testis development are normal in mice lacking testicular orphan nuclear receptor 2.
Shyr CR; Collins LL; Mu XM; Platt KA; Chang C
Mol Cell Biol; 2002 Jul; 22(13):4661-6. PubMed ID: 12052874
[TBL] [Abstract][Full Text] [Related]
24. TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC-3.
Mu X; Chang C
Prostate; 2003 Oct; 57(2):129-33. PubMed ID: 12949936
[TBL] [Abstract][Full Text] [Related]
25. The genomic structure and chromosomal location of the human TR2 orphan receptor, a member of the steroid receptor superfamily.
Lin DL; Wu SQ; Chang C
Endocrine; 1998 Apr; 8(2):123-34. PubMed ID: 9704569
[TBL] [Abstract][Full Text] [Related]
26. TR4 Nuclear Receptor Different Roles in Prostate Cancer Progression.
Lin SJ; Yang DR; Li G; Chang C
Front Endocrinol (Lausanne); 2015; 6():78. PubMed ID: 26074876
[TBL] [Abstract][Full Text] [Related]
27. An embryonic/fetal beta-type globin gene repressor contains a nuclear receptor TR2/TR4 heterodimer.
Tanabe O; Katsuoka F; Campbell AD; Song W; Yamamoto M; Tanimoto K; Engel JD
EMBO J; 2002 Jul; 21(13):3434-42. PubMed ID: 12093744
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in the study of testicular nuclear receptor 4.
Ding XF; Yu SC; Chen BD; Lin SJ; Chang C; Li GH
J Zhejiang Univ Sci B; 2013 Mar; 14(3):171-7. PubMed ID: 23463759
[TBL] [Abstract][Full Text] [Related]
29. SmTR2/4, a Schistosoma mansoni homologue of TR2/TR4 orphan nuclear receptor.
Hu R; Wu W; Niles EG; LoVerde PT
Int J Parasitol; 2006 Sep; 36(10-11):1113-22. PubMed ID: 16839558
[TBL] [Abstract][Full Text] [Related]
30. False responses of Renilla luciferase reporter control to nuclear receptor TR4.
Zhang D; Atlasi SS; Patel KK; Zhuang Z; Heaney AP
Mol Cell Biochem; 2017 Jun; 430(1-2):139-147. PubMed ID: 28210900
[TBL] [Abstract][Full Text] [Related]
31. The nuclear hormone receptor PPARγ as a therapeutic target in major diseases.
Schmidt MV; Brüne B; von Knethen A
ScientificWorldJournal; 2010 Nov; 10():2181-97. PubMed ID: 21057731
[TBL] [Abstract][Full Text] [Related]
32. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway.
Avallone R; Demers A; Rodrigue-Way A; Bujold K; Harb D; Anghel S; Wahli W; Marleau S; Ong H; Tremblay A
Mol Endocrinol; 2006 Dec; 20(12):3165-78. PubMed ID: 16959872
[TBL] [Abstract][Full Text] [Related]
33. TR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of DNA damage/repair system.
Lin SJ; Lee SO; Lee YF; Miyamoto H; Yang DR; Li G; Chang C
Carcinogenesis; 2014 Jun; 35(6):1399-406. PubMed ID: 24583925
[TBL] [Abstract][Full Text] [Related]
34. Testicular orphan nuclear receptor 4 is associated with the radio-sensitivity of prostate cancer.
Yu S; Wang M; Ding X; Xia L; Chen B; Chen Y; Zhang Z; Niu Y; Li G; Chang C
Prostate; 2015 Oct; 75(14):1632-42. PubMed ID: 26178291
[TBL] [Abstract][Full Text] [Related]
35. Probing the intermolecular interactions of PPARγ-LBD with polyunsaturated fatty acids and their anti-inflammatory metabolites to infer most potential binding moieties.
Muralikumar S; Vetrivel U; Narayanasamy A; N Das U
Lipids Health Dis; 2017 Jan; 16(1):17. PubMed ID: 28109294
[TBL] [Abstract][Full Text] [Related]
36. [PPARgamma variants and complex diseases].
Ji SL; Huang QY
Yi Chuan; 2006 Aug; 28(8):993-1001. PubMed ID: 16870588
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
Touyz RM; Schiffrin EL
Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
[TBL] [Abstract][Full Text] [Related]
38. Modulation of PPARgamma activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis.
Wang M; Tafuri S
J Cell Biochem; 2003 May; 89(1):38-47. PubMed ID: 12682906
[TBL] [Abstract][Full Text] [Related]
39. Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer.
Li MY; Yuan H; Ma LT; Kong AW; Hsin MK; Yip JH; Underwood MJ; Chen GG
Am J Respir Cell Mol Biol; 2010 Dec; 43(6):674-83. PubMed ID: 20081051
[TBL] [Abstract][Full Text] [Related]
40. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.
Shappell SB; Gupta RA; Manning S; Whitehead R; Boeglin WE; Schneider C; Case T; Price J; Jack GS; Wheeler TM; Matusik RJ; Brash AR; Dubois RN
Cancer Res; 2001 Jan; 61(2):497-503. PubMed ID: 11212240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
